Sunil Agarwal - Apr 8, 2024 Form 4 Insider Report for Astria Therapeutics, Inc. (ATXS)

Role
Director
Signature
/s/ Ben Harshbarger, as attorney-in-fact for Sunil Agarwal
Stock symbol
ATXS
Transactions as of
Apr 8, 2024
Transactions value $
$0
Form type
4
Date filed
4/9/2024, 08:11 AM
Previous filing
Apr 9, 2024
Next filing
May 31, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATXS Stock Option (Right to Buy) Award $0 +28.2K $0.00 28.2K Apr 8, 2024 Common Stock 28.2K $11.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on April 8, 2024 and is scheduled to vest as to one-third of the shares of common stock underlying the option on each anniversary of the grant date until the third anniversary of the grant date, subject to the director's continued service.